T. Rowe Price Investment Management, Inc., a registered investment adviser, initiated a new position in Cencora, Inc. (NYSE:COR) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 6,700,091 shares of the Healthcare company, valued at approximately $2.3B as of the filing date.
Cencora, Inc.'s stock currently trades at $364.29 with a market capitalization of $66.7B.


